Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Priorities in renal replacement programs.

V Bonomini1

  • 1Institute of Nephrology, Dialysis and Transplantation, St Orsola University Hospital, Bologna, Italy. vbonomini@libero.it

The International Journal of Artificial Organs
|June 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolution of knowledge in medicine (speech given at the University of Kosice--Slovak Republic--on October 6, 2006 on receiving honorary degree in medicine).

The International journal of artificial organs·2007
Same author

Bionic kidney.

Artificial cells, blood substitutes, and immobilization biotechnology·2003
Same author

Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group.

Transplant international : official journal of the European Society for Organ Transplantation·2000
Same author

Kidney, patient and new millennium nephrology.

Nephron·2000
Same author

Immune response following fresh arterial homograft replacement for aortoiliac graft infection.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1999
Same author

University of Bologna and medical knowledge.

The International journal of artificial organs·1999
Same journal

Therapeutic plasma exchange added to CRRT combined with hemoperfusion in wasp sting-associated AKI: A multicenter retrospective cohort study.

The International journal of artificial organs·2026
Same journal

Development of an early prediction model for ICU-acquired weakness in sepsis using PNI and SII.

The International journal of artificial organs·2026
Same journal

Foot care behaviors and perceived exercise benefits and barriers in diabetic hemodialysis patients.

The International journal of artificial organs·2026
Same journal

First clinical experience with citrate-anticoagulated CVVHD-based low-flow ECCO<sub>2</sub>R in severe hypercapnic respiratory failure.

The International journal of artificial organs·2026
Same journal

Carboxyhemoglobin levels for the detection of hemolysis in patients supported by left ventricular assist devices: A case series.

The International journal of artificial organs·2026
Same journal

Evaluation of arteriovenous fistulas of obtuse anastomosis in reducing thrombosis using computational fluid dynamics.

The International journal of artificial organs·2026
See all related articles

Achieving an ideal ranking for renal replacement therapy is currently aspirational. Future advancements in bioartificial kidneys, immunomodulators, and gene therapy are crucial for realizing this goal.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Immunology

Background:

  • Current renal replacement therapies aim for an ideal meritocratic ranking.
  • This ideal ranking remains largely theoretical in practice.

Purpose of the Study:

  • To explore the scientific advancements necessary to achieve an ideal ranking in renal replacement therapy.
  • To identify key areas for future research and development.

Main Methods:

  • Review of existing literature on renal replacement therapy.
  • Analysis of emerging scientific directions and plans.
  • Identification of key technologies such as bioartificial kidneys, novel immunomodulators, and gene therapy.

Main Results:

Related Experiment Videos

  • The concept of a meritocratic ranking for renal replacement therapy is established.
  • Significant scientific and technological advancements are required to bridge the gap between the ideal and the current reality.

    • Conclusions:

    • The realization of an ideal renal replacement therapy ranking is contingent upon the successful development and implementation of new scientific strategies.
    • Bioartificial kidneys, novel immunomodulators, and gene therapy represent promising avenues for future progress.